Indication
Gonadotropin-releasing hormone (GnRH) antagonist
3 clinical trials
4 products
1 drug
Clinical trial
A Randomized Control Trial to Compare the Euploid Rate of Blastocyst Between the Progestin-primed Ovarian Stimulation Protocol and the GnRH Antagonist Protocol in Patients Undergoing PGT-AStatus: Recruiting, Estimated PCD: 2024-12-01
Product
GnRH antagonistProduct
DuphastonClinical trial
A Randomized Control Trial to Compare the Euploid Rate of Blastocyst Between the PPOS (Progestin-primed Ovarian Stimulation) Protocol and the Gonadotropin-releasing Hormone (GnRH) Antagonist Protocol in Women With PCOS (Polycystic Ovary Syndrome) Undergoing PGT-A (Preimplantation Genetic Testing for Aneuploidy)Status: Not yet recruiting, Estimated PCD: 2025-12-01
Drug
MPAClinical trial
A Randomized Control Trial to Compare the Live Birth Rate Between the Progestin-primed Ovarian Stimulation Protocol and the GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response Undergoing IVFStatus: Completed, Estimated PCD: 2022-10-10
Product
ProgesteroneProduct
GnRH Antagonist